Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | TDO2 | P48775 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | BTK | Q06187 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.36 |
| ▸ | GSK3A | P49840 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24229511 | 0.83 | NPC1 (0.62) | NPC1RAB9AIDO1TDO2CYP1A2 | |
| SCHEMBL18858325 | 0.83 | IDO1 (0.43) | NPC1RAB9AIDO1TDO2CYP1A2 | |
| SCHEMBL128015 | 0.81 | NPC1 (0.54) | NPC1RAB9AIDO1TDO2CYP1A2 | |
| SCHEMBL29838915 | 0.80 | NPC1 (0.67) | NPC1RAB9AIDO1TDO2CYP1A2 | |
| SCHEMBL29493150 | 0.80 | NPC1 (0.67) | NPC1RAB9AIDO1TDO2CYP1A2 | |
| SCHEMBL729768 | 0.80 | NPC1 (0.67) | NPC1RAB9AIDO1TDO2CYP1A2 | |
| SCHEMBL17952949 | 0.80 | HSD17B1 (0.53) | IDO1TDO2HSD17B1HSD17B2 | |
| SCHEMBL12112872 | 0.80 | NPC1 (0.48) | NPC1RAB9AIDO1TDO2CYP1A2 | |
| SCHEMBL28880195 | 0.79 | NPC1 (0.65) | NPC1RAB9AIDO1TDO2CYP1A2 | |
| SCHEMBL18253264 | 0.78 | ASIC3 (0.50) | NPC1RAB9ACYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9935273-B2 | Fluoranthene derivative, light-emitting device material containing same, and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-9935273-B2 | Fluoranthene derivative, light-emitting device material containing same, and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| EP-2907803-A1 | FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT | Toray Industries, Inc. (JP) | 2015-08-19 | — | — | EP | disclosed |
| WO-2014057874-A1 | FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT | 東レ株式会社 (JP) | 2014-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | FMNL1, AFF2, LEF1 | NPC1 3688/4885RAB9A 1537/4885IDO1 2942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.